The healthcare data market is highly volatile and heavily saturated – with key providers dominating in this space. For funds tracking names like Roche, Eli Lilly and Sanofi, certain dataset types (such as claims and electronic health records) are an obvious default. However, this calls into question – what signals are funds missing? Or, as we aim to uncover in this report, could some signals be hiding in plain sight?